Human FZD7 adenoviral particles

The frizzled class receptor 7 (FZD7) gene encodes a member of the Frizzled family of proteins, which are key receptors in the Wnt signaling pathway. These pathways play key roles in embryonic development, tissue homeostasis, and cell proliferation, differentiation, and polarity. FZD7 is a seven-transmembrane domain protein that binds to Wnt ligands to initiate both canonical (β-catenin-dependent) and non-canonical (β-catenin-independent) signaling cascades. Dysregulation of FZD7 has been implicated in a variety of cancers, including colorectal, breast, and hepatocellular carcinomas, and its overexpression is often associated with tumor progression, metastasis, and poor prognosis. Due to its central role in the Wnt signaling pathway, FZD7 has emerged as a potential therapeutic target. Human FZD7 adenoviral particles are non-replicating viral vectors designed to efficiently deliver the FZD7 gene to mammalian cells. These particles take advantage of the natural ability of adenoviruses to infect a variety of cell types, both dividing and non-dividing, ensuring stable gene expression. The adenoviral backbone has been modified to eliminate pathogenic genes, improving safety while maintaining high transduction efficiency. After infection, the delivered FZD7 transgene is integrated into the host cell's transcriptional machinery, supporting overexpression studies to explore the role of FZD7 in Wnt signaling, cancer biology, or regenerative medicine. Researchers use these particles to explore the effects of FZD7 on behaviors such as cell migration, invasion, and stem cell properties, and to screen potential inhibitors. In addition, they can also serve as a platform for gene therapy development, especially for diseases associated with Wnt pathway dysfunction.